Pharmaceutical Executive July 6, 2023
Francis Pollaro

Senior editor Fran Pollaro chats with Sharlene Jenner, vice president of engagement strategy, Abelson Taylor about the transformative impact and ethical considerations of AI in the pharmaceutical industry, emphasizing its potential in data analysis and marketing, while also highlighting the pioneering work of AI companies in advancing drug discovery.

Welcome to a riveting episode of the Pharm Exec podcast, where we dive headfirst into the transformative world of AI in healthcare with Sharlene Jenner, vice president of engagement strategy with the award-winning agency Abelson Taylor. This enlightening conversation traverses the advancements and potential risks of AI, the revolution it is stirring in pharmaceutical marketing, and its game-changing role in understanding complex protein structures. Amid the rapid innovation, we explore the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Conferences / Podcast, Govt Agencies, Regulations, Technology, Trends
Microsoft supercharges Fabric with new data tools to accelerate enterprise AI workflows
Citizen Health Secures $14.5M for AI Platform for Rare Diseases
Microsoft and C3 AI Expand Partnership to Promote Enterprise AI
What Gen Z thinks about AI and work: LinkedIn
Jimini Health Launches with $8M for AI Therapist Assistant, Sage

Share This Article